Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLEGRO extension study of laquinimod in relapsing multiple sclerosis
2009-012989-30Phase 3Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of laquinimod in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: No formal primary endpoint. Started Jul 2009; status: terminated.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-012989-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012989-30.